dermatology

Sienna loses a quarter of its value over pivotal trial failure

https://pharmaphorum.com/news/sienna-loses-a-quarter-of-its-value-over-phase-3-trial-failure/

Novartis pays up to $1 billion for potential eczema drug

https://pharmaphorum.com/news/novartis-increases-its-immunology-footprint-with-1-billion-deal/

The sky’s the limit for LEO Pharma’s R&D hub

https://pharmaphorum.com/views-analysis-digital/skys-limit-leo-pharma-rd-hub/

FDA approves UCB’s Cimzia in plaque psoriasis

https://pharmaphorum.com/news/fda-ucbs-cimzia-plaque-psoriasis/

The Microbiome Movement – Skin Health & Dermatology Summit Has Arrived

https://pharmaphorum.com/partner-content/the-microbiome-movement-skin-health-dermatology-summit-has-arrived/

Boehringer pins hopes on novel psoriasis drug

https://pharmaphorum.com/news/boehringer-pins-hopes-on-novel-psoriasis-drug/

Sanofi makes double EU filing for cancer and asthma drugs

https://pharmaphorum.com/news/sanofi-makes-double-eu-filing-for-cancer-and-asthma-drugs/

FDA to review Sanofi’s Dupixent in asthma

https://pharmaphorum.com/news/fda-review-sanofis-dupixent-asthma/

Novartis trumpets long-term data for Cosentyx in psoriasis

https://pharmaphorum.com/news/novartis-trumpets-long-term-data-cosentyx-psoriasis/

«< 2 3 4 5 6 >

Close in 10 seconds

Pharmaphorum.com

Search